HCONRES 42 · 117th Congress · Health

Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Introduced 2021-07-21· Sponsored by Rep. McKinley, David B. [R-WV-1]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2021-07-22)

Plain Language Summary

[AI summary unavailable — showing source text] This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (17)

7 Democrats10 Republicans